NIH-funded research R21 grant

Understanding how tuberculosis bacteria survive and spread

Official title: Interrogating complex mycobacterial population structures using single-cell RNA sequencing

Funded at Weill Medical Coll of Cornell Univ · NIH-11095979 · Data updated 2026-11-12

This study is looking at how tuberculosis bacteria act on their own to find out which ones can survive antibiotics, with the hope of discovering ways to make treatment faster and stop the spread of the disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$211,875
NIH project number5R21AI176355-02
Project IDNIH-11095979 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with tuberculosis who are undergoing treatment or have been exposed to the disease.

Less likely to help

Patients with non-tuberculosis infections or those who have not been diagnosed with TB may not benefit from this research.

What this research studies

This research investigates the complex behaviors of tuberculosis (TB) bacteria at a single-cell level using advanced RNA sequencing techniques. By analyzing the genetic activity of individual TB bacteria, the study aims to identify specific populations that can survive antibiotic treatment and contribute to the spread of the disease. This approach seeks to uncover vulnerabilities in these bacteria that could lead to shorter treatment durations and reduced transmission rates. The research is particularly focused on understanding how these bacteria behave in the presence of antibiotics and during aerosol transmission.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for tuberculosis, potentially reducing the duration of therapy and the risk of transmission.

How similar studies have gone: Previous research has shown promise in using single-cell sequencing techniques to study bacterial populations, suggesting that this approach could yield valuable insights into tuberculosis.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Saito, Kohta — Weill Medical Coll of Cornell Univ
  • Study coordinator: Saito, Kohta

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.